SER

Serina Therapeutics Inc. Common Stock (SER)

Stock · AMEX · Health Care

$1.72as of 10/16/2026

Price chart

Open in TradingView

Active signals

High Beta100.0%
200 SMA Touch0.0%
Resistance level
$2
Industry
Biotechnology: Pharmaceutical Preparations

SER Signal Track Record

How signals performed across all stocks →

What SER's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown26+3.3%65%
Volume Spike23-3.2%35%
Bollinger Band Breakout21-10.0%33%
200-Day Moving Average TouchActive now13-7.5%23%
Any 20-session window (baseline)-3.0%42%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SER

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigoti…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
16

Fundamentals

1-day range
$1.72$1.83
Market cap
$35.24M
P/E (trailing)
—
P/E (forward)
-1.64
EPS (trailing)
$-1.14
Dividend yield
—
Beta
8.11
Avg. volume
64.5K
52-week range
$1.22$5.29

How Serina Therapeutics Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$130.0KR&D$13.15M (10119%)SG&A$11.00M (8459%)Tax$18.0K (14%)SER

Source: 10-K filed Mar 25, 2026 · via SEC EDGAR / Finnhub

Operating Income-$24.02M(-18478%)

Forecasts

2 analyst ratings

Buy 83%
Hold 17%
Sell 0%
1-year price forecast
High
$11
+539.5%
Median
$9.5
+452.3%
Low
$8
+365.1%

Serina Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • SER
    Serina Therapeutics Inc. Common Stock
    $1.72
    ▼ 3.91%
    Market cap $35.24MP/E —
    $1.22$5.29
  • LTRN
    Lantern Pharma Inc. Common Stock
    $0.668
    ▲ 0.15%
    Market cap $35.47MP/E —
    $0.651$4.58
  • NNVC
    NanoViricides Inc. Common Stock
    $1.38
    ▲ 0.73%
    Market cap $35.56MP/E —
    $0.85$2.23
  • BYSI
    BeyondSpring Inc. Ordinary Shares
    $0.559
    ▼ 3.95%
    Market cap $35.77MP/E —
    $0.5657$2.44
  • VERU
    Veru Inc. Common Stock
    $2.3
    ▼ 5.74%
    Market cap $37.08MP/E —
    $2.05$7.33
  • ENLV
    Enlivex Ltd. Ordinary Shares
    $0.205
    ▼ 8.48%
    Market cap $33.33MP/E 0.00
    $0.21$27.15
  • IXHL
    Incannex Healthcare Inc. Common Stock
    $2.82
    ▼ 2.08%
    Market cap $37.21MP/E —
    $2.49$14.91

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
12.11M
Disposed
859.1K

Institutional Ownership

March 31, 2026

Total shares held
1.43M
Total value held
$2.78M
Institutional holders
22
Top holders this quarter
  • Unknown1.00M
  • Unknown159.1K
  • Unknown67.5K
  • Unknown65.0K
  • Unknown58.3K
  • Unknown39.7K
  • Unknown18.8K
  • Unknown12.8K
  • Unknown4.0K
  • Unknown3.6K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.